SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-190886
Filing Date
2015-05-18
Accepted
2015-05-18 07:01:00
Documents
13
Period of Report
2015-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927999d8k.htm 8-K 30908
2 EX-99.1 d927999dex991.htm EX-99.1 14270
3 EX-99.2 d927999dex992.htm EX-99.2 35048
4 GRAPHIC g927999exas1gbgd.jpg GRAPHIC 31417
5 GRAPHIC g927999exas2gbgd.jpg GRAPHIC 37787
6 GRAPHIC g927999exas3gbgd.jpg GRAPHIC 41566
7 GRAPHIC g927999exas4gbgd.jpg GRAPHIC 51373
8 GRAPHIC g927999exas5gbgd.jpg GRAPHIC 54459
9 GRAPHIC g927999exas6gbgd.jpg GRAPHIC 40033
10 GRAPHIC g927999exas7gbgd.jpg GRAPHIC 37105
11 GRAPHIC g927999ima1.jpg GRAPHIC 10694
12 GRAPHIC g927999img1.jpg GRAPHIC 32660
13 GRAPHIC g927999img2.jpg GRAPHIC 31746
  Complete submission text file 0001193125-15-190886.txt   591083
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 15871823
SIC: 2834 Pharmaceutical Preparations